Rocket Lab Stock Drops as Neutron Delay to 2027 Overshadows Record Revenue

Rocket Lab shares fell after the company pushed Neutron’s first launch to no earlier than 2027, despite posting record third-quarter revenue and a sharply larger backlog. Investors are weighing strong demand against rising losses, margin pressure and a longer path to profitability.

Rocket Lab stock fell sharply after the company confirmed that its Neutron rocket will not launch before 2027, extending the timeline for the product many investors see as central to the company’s long-term profit story.

The market reaction came despite a strong operating update. Third-quarter revenue reached a record $267.8 million, up 73% from a year earlier, while backlog climbed to $3.57 billion. But the combination of a wider net loss, lower gross margins and an open-ended Neutron schedule pushed the focus back to execution risk.

For shareholders, the key issue is no longer whether demand exists. It is whether Rocket Lab can convert that demand into profitable growth before delays, dilution and higher rates further pressure valuation.

Key Facts

  • Rocket Lab reported third-quarter 2026 revenue of $267.8 million, up 73% from $155.1 million a year earlier.
  • The company’s backlog rose 52% in one quarter to a record $3.57 billion, including 117 launches under contract.
  • Net loss widened to $79.7 million, or $0.12 per share, versus a loss of $18.3 million, or $0.03 per share, a year earlier.
  • Neutron’s first launch is now targeted for no earlier than 2027 after previously being expected in late 2026.
  • Cash and marketable securities totaled about $4.7 billion at September 30, while weighted-average shares outstanding rose 23% year over year.

Rocket Lab stock and the Neutron delay

The central development was the revised Neutron timeline. Rocket Lab had previously pointed to a late-2026 debut for the medium-lift rocket, but now says the first launch is expected no earlier than 2027, without giving a specific month or quarter. That lack of precision matters because Neutron is widely viewed as the company’s future margin engine.

Rocket Lab’s existing Electron vehicle has established the company as a credible launch provider, but its economics are constrained by smaller payload capacity. Neutron is designed to serve larger commercial constellations, civil programs and national-security missions, with a base launch price that has reportedly moved up to $70 million from $55 million on some missions. If execution stays on track, Neutron could materially increase revenue per launch and improve profitability.

Instead, the delay extends the period in which Rocket Lab remains heavily reliant on Space Systems, the satellite and components business that now contributes roughly 80% of revenue. That business is growing quickly, but it tends to carry lower margins than launch. As a result, investors are seeing a company with real commercial momentum but a slower route to the higher-margin mix needed to support its premium valuation.

Rocket Lab is proving that demand is strong, but the stock is being priced on when Neutron can turn growth into profits.

Record growth, but margins and losses remain under pressure

Operationally, the quarter was far from weak. Product revenue nearly doubled to $197.5 million, supported by spacecraft work tied to NASA, the U.S. Space Force, Globalstar and Viasat. Service revenue rose 38% to $70.3 million. The company also guided fourth-quarter revenue to $270 million to $290 million, implying another record period and putting full-year 2026 revenue close to $1 billion.

Even so, profitability trends were less encouraging. GAAP gross margin fell to 33.6% from 37.0% a year earlier, while non-GAAP gross margin declined to 38.4% from 41.9%. The net loss widened sharply to $79.7 million. Some of that deterioration reflected one-time items, including a $27.3 million loss tied to debt extinguishment and $21.3 million in transaction costs related to the pending Iridium acquisition. But investors are also responding to a broader concern: strong top-line growth is not yet flowing through to durable earnings power.

Backlog strength reinforces demand for launch and spacecraft capacity

If there was one figure that underscored market demand, it was backlog. Rocket Lab ended the quarter with $3.57 billion in contracted backlog, up from $2.2 billion after the first quarter and $1.85 billion at the end of 2025. The launch backlog alone reached 117 missions, while more than 55 spacecraft are in development or production.

Neutron is already a meaningful contributor to that future pipeline. The company added more than $515 million in Neutron launch contracts during the quarter, bringing the rocket’s backlog to 16 missions before its first flight. That suggests customers are willing to commit early in an environment where launch capacity remains tight. Still, backlog is only as valuable as the company’s ability to deliver on schedule, and every shift in Neutron timing pushes some of that revenue further into the future.

Implications for Investors

For investors, Rocket Lab remains a high-growth but high-expectation story. On one hand, the company has several attractive qualities: revenue growth above 70%, a nearly $3.6 billion backlog, rising demand for launch and spacecraft services, and a cash position of roughly $4.7 billion with very limited debt. Those factors reduce near-term liquidity risk and support continued investment in launch infrastructure, manufacturing and acquisitions.

On the other hand, the stock still reflects a business being valued on future outcomes rather than present earnings. At a market value of about $36.9 billion and trailing 12-month revenue of $882.2 million, Rocket Lab trades at a multiple that leaves little room for repeated schedule slips. The company also expanded its share count materially, with weighted-average shares up 23% from a year earlier, meaning future gains must be spread across a larger base.

Investors should watch three variables closely over the next several quarters. First is the Neutron timeline: even a firm launch window could improve confidence. Second is margin stabilization, particularly whether gross margin can recover toward the mid-30% range or better as revenue scales. Third is the pending Iridium acquisition, which could add recurring communications revenue and diversify the business model, but also introduces integration and execution risk.

Rocket Lab’s investment case is still intact, but it has become more timing-sensitive. The company has demonstrated demand, pricing power and balance-sheet strength; the next phase depends on proving that Neutron can launch on schedule and that growth can translate into profits.

Ultima Markets